Page last updated: 2024-10-29

iomeprol and Ventricular Dysfunction, Left

iomeprol has been researched along with Ventricular Dysfunction, Left in 1 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palumbo, A1
Maffei, E1
Martini, C1
Messalli, G1
Seitun, S1
Malagò, R1
Aldrovandi, A1
Emiliano, E1
Cuttone, A1
Weustink, A1
Mollet, N1
Cademartiri, F1

Other Studies

1 other study available for iomeprol and Ventricular Dysfunction, Left

ArticleYear
Functional parameters of the left ventricle: comparison of cardiac MRI and cardiac CT in a large population.
    La Radiologia medica, 2010, Volume: 115, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Female; Humans; Image Interpre

2010